Teva Sues FDA Alleging Unlawful Interpretation of the Definition of “First Applicant”

October 24, 2018

Tribal Immunity Cannot Be Asserted to Escape IPR Proceedings

July 25, 2018

Now Available! Seyfarth Shaw’s BioLoquitur Bulletin: Drugs Available in 2018 for Generic Competition

April 5, 2018

FDA’s Office of Generic Drugs: 2017 Annual Report Highlights

March 9, 2018

Webinar: Bridging the Gap Between EU and U.S. Biotech Inventions Protection

February 22, 2018

Webinar: Biosimilar Litigation and Your BPCIA Compliance: Key Strategies In Light of AbbVie v. Boehringer

February 20, 2018

Now Available! Seyfarth Shaw’s Hatch-Waxman and Biosimilars Litigation: 2017 Year-in-Review

February 8, 2018

Is Medical Marijuana Really Medicinal?

November 8, 2017

Is Medical Marijuana Really Medicinal?

November 7, 2017

FDA Provides New Product Specific Guidance for Development of Certain Generic Drug Products

November 6, 2017